metoclopramide has been researched along with Injuries, Radiation in 3 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine the mechanism of action of radiation-induced emesis by determining the incidence of radiation-induced emesis following hemibody irradiation; the effects of specific antiemetics especially ondansetron, a 5-hydroxytryptamine receptor antagonist, and to determine the relationship between radiation-induced emesis and serotonin (5-hydroxytryptamine) through its active metabolite, 5-hydroxyindoleacetic acid (5-HIAA)." | 5.07 | On the mechanism of radiation-induced emesis: the role of serotonin. ( Anderson, RF; Hoffman, LG; Ornitz, RD; Scarantino, CW, 1994) |
| "85 patients with differentiated thyroid cancer who received 131I." | 2.79 | Management of gastrointestinal complaints in differentiated thyroid cancer patients treated with (131)I: comparison of the efficacy of pantoprazole, metoclopramide, and ondansetron - a randomized clinical trial. ( Asli, IN; Assadi, M; Baharfar, N; Delavari, S; Fatholahi, L; Javadi, H; Mirzababaee, M; Motazdian, M; Naghshine, R; Seifollahi, S; Shafiei, B; Tabeie, F, 2014) |
| "Ondansetron (GR 38032F) is a highly selective 5-HT3 receptor antagonist, one of a new class of compounds which may have several therapeutic applications." | 2.38 | Ondansetron. Therapeutic use as an antiemetic. ( Heel, RC; Milne, RJ, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirzababaee, M | 1 |
| Shafiei, B | 1 |
| Seifollahi, S | 1 |
| Motazdian, M | 1 |
| Fatholahi, L | 1 |
| Delavari, S | 1 |
| Naghshine, R | 1 |
| Baharfar, N | 1 |
| Tabeie, F | 1 |
| Javadi, H | 1 |
| Assadi, M | 1 |
| Asli, IN | 1 |
| Scarantino, CW | 1 |
| Ornitz, RD | 1 |
| Hoffman, LG | 1 |
| Anderson, RF | 1 |
| Milne, RJ | 1 |
| Heel, RC | 1 |
1 review available for metoclopramide and Injuries, Radiation
| Article | Year |
|---|---|
Ondansetron. Therapeutic use as an antiemetic.
Topics: Antiemetics; Antineoplastic Agents; Humans; Imidazoles; Metoclopramide; Nausea; Ondansetron; Radiati | 1991 |
2 trials available for metoclopramide and Injuries, Radiation
| Article | Year |
|---|---|
Management of gastrointestinal complaints in differentiated thyroid cancer patients treated with (131)I: comparison of the efficacy of pantoprazole, metoclopramide, and ondansetron - a randomized clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiemetics; Female; Gastrointestinal Diseases; Humans; Iod | 2014 |
On the mechanism of radiation-induced emesis: the role of serotonin.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Hemibody Irradiation; Humans; Hydroxyindoleacetic | 1994 |